Cortexyme, Inc. is a company in the U.S. stock market and it is a holding in 33 U.S.-traded ETFs. CRTX has around 1.8M shares in the U.S. ETF market. The largest ETF holder of CRTX is the SPDR S&P Biotech ETF (XBI), with approximately 643.57K shares. Investors may also find of interest that the ETF with the largest allocation to CRTX stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 1.82%. On average, U.S. ETFs allocate 0.19% of CRTX to their portfolios.
Additionally, CRTX is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CRTX as a holding is the ProShares UltraPro Russell2000 (URTY), with a return of 167.77%.